CRVO William Robert Elder buys $18K worth of shares
Aug 27, 2024, 8:33 PM
-22.12%
What does CRVO do
CervoMed, a Boston-based biotechnology company with 8 employees, focuses on developing neflamapimod for neurodegenerative diseases and is conducting the RewinD-LB Phase 2b trial for dementia with Lewy bodies. The drug aims to modify disease processes and improve synaptic dysfunction.
William Robert Elder bought 1,000 shares of CRVO on 27 August at $18.16 per share, worth a total of $18K. They now own 1,267 CRVO shares, or a 375% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
